Latest News and Press Releases

   Achilles Therapeutics Announces Grant of European Patent Covering Use of Selectively Expanded T cells Targeting Clonal Neoantigens for the Treatment of Cancer - Related patent recently granted and...

   Achilles Therapeutics Announces Grant of European Patent Covering Use of Selectively Expanded T cells Targeting Clonal Neoantigens for the Treatment of Cancer - Related patent recently granted and...

   Achilles Therapeutics appoints Professor Karl Peggs as Chief Medical Officer Stevenage, UK 7 October 2020 – Achilles Therapeutics (“Achilles”), a clinical-stage oncology company developing...

   Achilles Therapeutics appoints Professor Karl Peggs as Chief Medical Officer Stevenage, UK 7 October 2020 – Achilles Therapeutics (“Achilles”), a clinical-stage oncology company developing...

   Achilles Therapeutics doses first patient in Phase I/II Study in advanced non-small cell lung cancer Stevenage, UK 23 June 2020 – Achilles Therapeutics (“Achilles”), a clinical stage...

   Achilles Therapeutics doses first patient in Phase I/II Study in advanced non-small cell lung cancer Stevenage, UK 23 June 2020 – Achilles Therapeutics (“Achilles”), a clinical stage...

   Achilles Therapeutics doses first patient in Phase I/II Study in recurrent or metastatic malignant melanoma with first TIL therapy to specifically target clonal neoantigens Stevenage, UK 29 May...

   Achilles Therapeutics doses first patient in Phase I/II Study in recurrent or metastatic malignant melanoma with first TIL therapy to specifically target clonal neoantigens Stevenage, UK 29 May...

Achilles Therapeutics announces formation of Scientific Advisory Board - World-leading experts in oncology, immunology and R&D will advise the Company as it advances pipeline of pioneering cancer...

Achilles Therapeutics announces formation of Scientific Advisory Board - World-leading experts in oncology, immunology and R&D will advise the Company as it advances pipeline of pioneering cancer...